Does pioglitazone prevent macrovascular events in patients with type 2 diabetes?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 11, 2006
has subject area
- 11 Medical and Health Sciences (FoR)
- Adult (MeSH)
- Aged (MeSH)
- Cardiovascular Diseases (MeSH)
- Diabetes Mellitus, Type 2 (MeSH)
- Double-Blind Method (MeSH)
- Female (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Hypoglycemic Agents (MeSH)
- Insulin Resistance (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Pioglitazone (MeSH)
- Placebos (MeSH)
- Risk Factors (MeSH)
- Thiazolidinediones (MeSH)